Alpine Woods Capital Investors, LLC Amgen Inc Transaction History
Alpine Woods Capital Investors, LLC
- $512 Million
- Q1 2024
A detailed history of Alpine Woods Capital Investors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 25,736 shares of AMGN stock, worth $8.13 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
25,736
Previous 30,411
15.37%
Holding current value
$8.13 Million
Previous $8.76 Million
16.45%
% of portfolio
1.43%
Previous 1.24%
Shares
26 transactions
Others Institutions Holding AMGN
# of Institutions
2,936Shares Held
401MCall Options Held
6.59MPut Options Held
6.6M-
Vanguard Group Inc Valley Forge, PA52.1MShares$16.5 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$15.2 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.2 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.61 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.41 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $169B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...